CCORF Maintains Kenvue(KVUE.US) With Buy Rating, Raises Target Price to $27

Futu News05:31 · Ratings

Kenvue Likely to See 'Muted' Q3 Amid Skin Health & Beauty Challenges, RBC Says

MT Newswires04:54

Kenvue Stock Hits 52-week High at $23.55 Amid Robust Growth

Investing01:40

RBC Capital Maintains Kenvue(KVUE.US) With Hold Rating, Maintains Target Price $24

Futu NewsNov 5 20:31 · Ratings

Kenvue Canada Expands Ontario Manufacturing Facility to Boost Production of Over-the-Counter Medicines

Yahoo FinanceNov 5 09:19

Is There An Opportunity With Kenvue Inc.'s (NYSE:KVUE) 35% Undervaluation?

Simply Wall StNov 5 00:44